Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$419,437,621
+$30,110,255 QoQ
Shares Held
3,264,106
+0.9% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#77
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AVIVA PLC holds $4,883,087,810 across 10 Drug Manufacturers - General names. MRK ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,899,700 | $2,066,801,114 | |
| 2 | LLY |
ELI LILLY & Co
|
718,261 | $861,503,863 | |
| 3 | JNJ |
Johnson & Johnson
|
2,162,709 | $549,263,204 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
3,264,106 | $419,437,621 | |
| 5 | ABBV |
AbbVie Inc.
|
1,664,656 | $418,894,035 | |
| 6 | AMGN |
Amgen Inc
|
471,664 | $170,798,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,183,858 | $149,568,619 | |
| 8 | PFE |
Pfizer Inc
|
4,977,327 | $119,854,034 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,437,621 | 3,264,106 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $389,327,366 | 3,236,573 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $303,922,882 | 2,887,354 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $232,679,642 | 2,772,306 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $212,444,779 | 2,683,739 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $228,585,239 | 2,546,627 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $218,907,530 | 2,200,518 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $258,252,587 | 2,274,151 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $274,696,848 | 2,218,876 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $249,246,028 | 1,888,943 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $192,962,456 | 1,769,973 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $184,273,911 | 1,789,936 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $215,343,241 | 1,866,221 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $150,913,044 | 1,418,489 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $170,895,508 | 1,540,293 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $115,154,324 | 1,337,138 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $134,077,792 | 1,470,635 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $126,469,244 | 1,541,368 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $161,761,901 | 2,110,672 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $142,520,247 | 1,897,487 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $152,220,697 | 1,957,319 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $147,654,487 | 1,915,351 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $176,951,234 | 2,163,219 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $188,708,515 | 2,274,966 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $178,303,646 | 2,305,749 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $128,821,357 | 1,674,310 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||